v3.26.3
SHARE-BASED PAYMENTS TRANSACTIONS
6 Months Ended
Jun. 30, 2026
Notes and other explanatory information [abstract]  
SHARE-BASED PAYMENTS TRANSACTIONS

20 SHARE-BASED PAYMENTS TRANSACTIONS

 

Equity-settled share option scheme of the Company

 

The Company’s share option scheme (the “Scheme”) was adopted pursuant to an ordinary resolution of the shareholders passed on September 1, 2019 for the primary purpose of providing incentives to directors and eligible employees and will expire on the date of the listing of shares of the Company. Under the Scheme, the directors of the Company may grant options to eligible employees, including directors of the Company and its subsidiaries, to subscribe for shares in the Company.

 

At June 30, 2026, the number of shares in respect of which options had been granted and remained outstanding under the Scheme was 1,880,000 (2025: 1,880,000), representing 1% (2025: 1%) of the shares of the Company in issue. The total number of shares in respect of which options may be granted under the Scheme is not permitted to exceed 10% of the shares of the Company in issue at any point in time, without prior approval from the Company’s shareholders. The number of shares issued and to be issued in respect of which options granted and may be granted to any individual in any one year is not permitted to exceed 1% of the shares of the Company in issue at any point in time, without prior approval from the Company’s shareholders.

 

Options granted must be taken up within 1 month of the date of grant, upon payment of HK$1 (equivalent to USD0.1275) per option. Options may be exercised at any time from the date of grant of the share option to the 10th anniversary of the date of grant. The exercise price is HK$4.661 or equivalent to USD0.594 per share (equivalent to HK$37.288 or equivalent to USD4.754 per ADS).

 

a) Details of specific categories of options are as follows:

 

Date of grant   Vesting period   Exercise period   Exercise Price   Exercise dates
September 30, 2019   Vested upon grant date  

September 30, 2019 – September 29, 2029

  HK$4.661 per share   Not yet exercised
                 
August 18, 2020   Vested upon grant date  

August 18, 2020 – August 17, 2030

  HK$4.661 per share   Not yet exercised

 

 

b) The following table discloses movements of the Scheme during the period:

 

Option grant date  Outstanding at January 1, 2026   Granted during period   Exercised during period   Forfeited during period   Expired during period   Outstanding at June 30, 2026 
September 30, 2019   1,880,000    -    -    -    -    1,880,000 
Exercisable at the end of the period   1,880,000                        1,880,000 
                               
Weighted average exercise price  HK$4.661    -    -    -    -   HK$4.661 

 

In respect of the share options exercised during the period, the weighted average share price at the dates of exercise was HK$4.661 (2025: HK$4.661) or equivalent to USD0.594 (2025: USD0.594) per share.

 

 

  c) During the year ended December 31, 2021, options were granted on 18 August 2020. The estimated fair values of the options granted on this date is HK$0.
     
  d) These fair values were calculated using Hull-White Enhanced Model. The inputs into the model on option grant dates were as follows:

 

Underlying stock price  HK$ 0.235 
Exercise price  HK$ 4.661 
Expected volatility    2.86 
Expected life    10 years 
Risk-free rate    1.20%
Expected dividend yield    - 

 

  e) Expected volatility was determined by using the historical volatility of the comparable companies adopted by the independent valuation expert. The expected life used in the model has not been adjusted which is based on the exercise period as specified under the terms and conditions of the share options.
     
  f) The Group did not recognize any share-based payment expense in relation to share options granted by the Company because assessed option value by the independent valuation expert on grant date is zero.